Lauster F[Author] - Search Results

Year	Number of Results
1990	2
1992	1
1993	2
2005	1
2008	1
2009	1
2017	1
2022	0

1

[Costs associated with multiresistant bacteria in neurorehabilitation].

Roukens R, Lauster F, Bara M, Eifert B, Willemsen D, Randall T, Herzog J, Wendt C, Schmidt-Wilcke T, Knecht S. Roukens R, et al. Among authors: lauster f. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Oct;60(10):1075-1082. doi: 10.1007/s00103-017-2606-x. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017. PMID: 28812106 Review. German.

2

Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial.

Pohl M, Mayr P, Mertl-Roetzer M, Lauster F, Haslbeck M, Hipper B, Steube D, Tietjen M, Eriksen J, Rahlfs VW. Pohl M, et al. Among authors: lauster f. JPEN J Parenter Enteral Nutr. 2009 Jan-Feb;33(1):37-49. doi: 10.1177/0148607108324582. Epub 2008 Nov 14. JPEN J Parenter Enteral Nutr. 2009. PMID: 19011146 Clinical Trial.

3

Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial.

Pohl M, Mayr P, Mertl-Roetzer M, Lauster F, Lerch M, Eriksen J, Haslbeck M, Rahlfs VW. Pohl M, et al. Among authors: lauster f. Eur J Clin Nutr. 2005 Nov;59(11):1221-32. doi: 10.1038/sj.ejcn.1602232. Eur J Clin Nutr. 2005. PMID: 16077745 Clinical Trial.

4

Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMP.

Lauster F, Gerzer R, Weil J, Fülle HJ, Schiffl H. Lauster F, et al. Nephrol Dial Transplant. 1990;5(5):356-61. doi: 10.1093/ndt/5.5.356. Nephrol Dial Transplant. 1990. PMID: 2165225

5

The postdialytic plasma cyclic guanosine 3':5'-monophosphate level as a measure of fluid overload in chronic hemodialysis.

Lauster F, Fülle HJ, Gerzer R, Schiffl H. Lauster F, et al. J Am Soc Nephrol. 1992 Mar;2(9):1451-4. doi: 10.1681/ASN.V291451. J Am Soc Nephrol. 1992. PMID: 1320949 Free article.

6

Plasma cGMP level as a marker of the hydration state in renal replacement therapy.

Lauster F, Heim JM, Drummer C, Fülle HJ, Gerzer R, Schiffl H. Lauster F, et al. Kidney Int Suppl. 1993 Jun;41:S57-9. Kidney Int Suppl. 1993. PMID: 8391608

7

Plasma ANP and cGMP levels in CAPD patients.

Lauster F, Heim JM, Drummer C, Gerzer R, Schiffl H. Lauster F, et al. Contrib Nephrol. 1993;101:44-50. doi: 10.1159/000422106. Contrib Nephrol. 1993. PMID: 8385595 No abstract available.

8

Effects of a small bolus dose of ANF in healthy volunteers and in patients with volume retaining disorders.

Heim JM, Gottmann K, Weil J, Schiffl H, Lauster F, Loeschke K, Gerzer R. Heim JM, et al. Among authors: lauster f. Klin Wochenschr. 1990 Jul 17;68(14):709-17. doi: 10.1007/BF01647578. Klin Wochenschr. 1990. PMID: 2168005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results